Norway
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 128.71 M
|
Dec. 31, 2023 | USD 15.98 | -1.62% |
|
Norway |
|
2 |
USD 6.19 M
|
Dec. 31, 2023 | USD 5.88 | -1.04% |
|
Norway |
|
3 |
USD 2.48 M
|
Dec. 31, 2023 | USD 1.20 | -0.29% |
|
Norway |
|
4 |
USD -500.00 K
|
Dec. 31, 2023 | USD 5.71 | 2.33% |
|
Norway |
|
5 |
USD -702.93 K
|
Dec. 31, 2023 | USD 0.22 | 4.62% |
|
Norway |
|
6 |
USD -932.17 K
|
Dec. 31, 2023 | USD 3.46 | 4.14% |
|
Norway |
|
7 |
USD -2.18 M
|
Dec. 31, 2023 | USD 0.11 | -3.45% |
|
Norway |
|
8 |
USD -3.47 M
|
Dec. 31, 2023 | USD 1.36 | 33.77% |
|
Norway |
|
9 |
USD -6.42 M
|
Dec. 31, 2023 | USD 0.54 | -0.84% |
|
Norway |
|
10 |
USD -6.62 M
|
Dec. 31, 2023 | USD 3.42 | 0.44% |
|
Norway |
|
11 |
USD -10.51 M
|
Dec. 31, 2023 | USD 0.17 | -2.50% |
|
Norway |
|
12 |
USD -10.98 M
|
Dec. 31, 2023 | USD 0.57 | 1.53% |
|
Norway |
|
13 |
USD -18.64 M
|
Dec. 31, 2023 | USD 0.77 | -0.80% |
|
Norway |
|
14 |
USD -21.18 M
|
Dec. 31, 2023 | USD 0.19 | 2.37% |
|
Norway |
|
15 |
USD -21.92 M
|
Dec. 31, 2023 | USD 1.21 | 2.68% |
|
Norway |
|
16 |
USD -43.86 M
|
Dec. 31, 2023 | USD 0.23 | 0.44% |
|
Norway |
The Biotechnology company in Norway with the highest EBIT is Borregaard ASA (Oslo Stock Exchange: BRG.OL) at USD 128.71 M.
The Biotechnology company in Norway with the lowest EBIT is Nykode Therapeutics AS (Oslo Stock Exchange: NYKD.OL) at USD -43.86 M.
The top 10 Biotechnology companies in Norway by EBIT are Borregaard ASA, AKVA group ASA, ArcticZymes Technologies ASA, Aker BioMarine AS, Thor Medical ASA, Gentian Diagnostics ASA, PCI Biotech Holding ASA, Lifecare AS, NEXT Biometrics Group ASA and Andfjord Salmon AS.
The bottom 10 Biotechnology companies in Norway by EBIT are Nykode Therapeutics AS, Norcod AS, Ultimovacs ASA, BerGenBio ASA, Salmon Evolution ASA, Hofseth BioCare ASA, Andfjord Salmon AS, NEXT Biometrics Group ASA, Lifecare AS and PCI Biotech Holding ASA.